000 01347 a2200349 4500
005 20250512032905.0
264 0 _c19881209
008 198812s 0 0 eng d
022 _a0027-8424
024 7 _a10.1073/pnas.85.21.8037
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChen, L
245 0 0 _aGrowth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2.
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cNov 1988
300 _a8037-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBreast Neoplasms
_xpathology
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCell Line
650 0 4 _aDNA
_xmetabolism
650 0 4 _aEscherichia coli
_xgenetics
650 0 4 _aHumans
650 0 4 _aInterferon Type I
_xpharmacology
650 0 4 _aLeukemia
_xpathology
650 0 4 _aLymphoma
_xpathology
650 0 4 _aRecombinant Proteins
_xpharmacology
700 1 _aMory, Y
700 1 _aZilberstein, A
700 1 _aRevel, M
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 85
_gno. 21
_gp. 8037-41
856 4 0 _uhttps://doi.org/10.1073/pnas.85.21.8037
_zAvailable from publisher's website
999 _c3060690
_d3060690